Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay

Journal of Translational Medicine

Volumn 2, Issue , 2004, Pages

  Shafer Weaver, Kimberly A ^a   Sayers, Thomas ^a   Kuhns, Douglas B ^a   Strobl, Susan L ^a   Burkett, Mark W ^a   Baseler, Michael ^a   Malyguine, Anatoli ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; CALCIUM ION; CHROMIUM 51; ESTER DERIVATIVE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; GAMMA INTERFERON; GLYCOPROTEIN; GRANZYME B; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1;

ACCURACY; ARTICLE; CELL COUNT; CELL DESTRUCTION; CELL INTERACTION; CELL SECRETION; CELL STRAIN K 562; CONTROLLED STUDY; DEGRANULATION; EFFECTOR CELL; ENZYME INHIBITION; ENZYME LINKED IMMUNOSPOT ASSAY; ENZYME RELEASE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INTERFERON PRODUCTION; INTERMETHOD COMPARISON; LYMPHOCYTOTOXICITY; LYMPHOID CELL LINE; LYMPHOKINE ACTIVATED KILLER CELL; PROCESS OPTIMIZATION; PROTEIN EXPRESSION; TITRIMETRY;

EID: 17644398661     PISSN: 14795876     EISSN: None     Source Type: Journal    
DOI: 10.1186/1479-5876-2-31     Document Type: Article

References (50)

1. Wu J, Cherwinski H, Spies T, Phillips JH, Lanier LL: DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J Exp Med 2000, 192:1059-1068.
2. Berke G: The CTL's kiss of death. Cell 1995, 81:9-12.
3. Nagata S, Golstein P: The Fas death factor. Science 1995, 267:1449-1456.
4. Rouvier E, MF MF Luciani, Golstein P: Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J Exp Med 1993, 177:195-200.
5. Kagi D, F F Vignaux, Ledermann B, Burki K, Depraetere V, Nagata S, Hengartner H, Golstein P: Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994, 265:528-530.
6. Lowin B, Hahne M, Mattmann C, Tschopp J: Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 1994, 370:650-652.
7. Tschopp J, Nabholz M: Perforin-mediated target cell lysis by cytolytic T lymphocytes. Annu Rev Immunol 1990, 8: 279-302.
8. Jenne DE, Tschopp J: Granzymes, a family of serine proteases released from granules of cytolytic T lymphocytes upon T cell receptor stimulation. Immunol Rev 1988, 103:53-71.
9. Podack ER, Kupfer A: T-cell effector functions: mechanisms for delivery of cytotoxicity and help. Annu Rev Cell Biol 1991, 7:479-504.
10. Podack ER: Execution and suicide: cytotoxic lymphocytes enforce Draconian laws through separate molecular pathways. Curr Opin Immunol 1995, 7:11-16.
11. Peters PJ, Geuze HJ, Donk HA van der, Borst J: A new model for lethal hit delivery by cytotoxic T lymphocytes. Immunol Today 1990, 11:28-32.
12. Kupfer A, Singer SL, Dennert G: On the mechanism of unidirectional killing in mixtures of two cytotoxic T lymphocytes. Unidirectional polarization of cytoplasmic organelles and the membrane-associated cytoskeleton in the effector cell. J Exp Med 1986, 163:489-498.
13. Young JD, Leong LG, Liu CC, Damiano A, Wall DA, Cohn ZA: Isolation and characterization of a serine esterase from cytolytic T cell granules. Cell 1986, 47:183-194.
14. Stinchcombe JC, Bossi G, Booth S, Griffiths GM: The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity 2001, 15:751-761.
15. Kagi D, Hengartner H: Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Curr Opin Immunol 1996, 8:472-477.
16. Clark WR, Walsh CM, Glass AA, Huang MT, R R Ahmed, Matloubian M: Cell-mediated cytotoxicity in perforin-less mice. Int Rev Immunol 1995, 13:1-14.
17. Liu CC, PM PM Persechini, Young JD: Perforin and lymphocyte-mediated cytolysis. Immunol Rev 1995, 146: 145-175.
18. Henkart PA: Mechanism of lymphocyte-mediated cytotoxicity. Annu Rev Immunol 1985, 3:31-58.
19. Martz E: Overview of CTL-target adhesion and other critical events in th cytotoxic mechanism. Cytotoxic Cells: Recognition, Effector Function, Generation, and Methods Edited by: M Sitkovsky and P Henkart. Boston, MA, Birkhauser; 1993:9-48.
20. Brunner KT, Manuel J, Cerottini JC, Chapuis B: Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 1968, 14:181-196.
21. Trinchieri G, Perussia B: Human natural killer cells: biologic and pathologic aspects. Lab Invest 1984, 50: 489-513.
22. Smyth MJ, Trapani JA: Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today 1995, 16:202-206.
23. Finn OJ, Lotze MT: A decade in the life of tumor immunology. Clin Cancer Res 2001, 7:759s-760s.
24. Rininsland FH, Helms T, Asaad RJ, Boehm BO, Tary-Lehmann M: Granzyme B ELISPOT assay for ex vivo measurements of T cell immunity. J Immunol Methods 2000, 240:143-155.
25. Shafer-Weaver Kimberly, Sayers Thomas, Strobl Susan, Derby Eric, Ulderich Tracy, Baseler Michael, Malyguine Anatoli: The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity. Journal of Translational Medicine 2003, 1:14.
26. Cesano A, Santoli D: Two unique human leukemic T-cell lines endowed with a stable cytotoxic function and a different spectrum of target reactivity analysis and modulation of their lytic mechanisms. In Vitro Cell Dev Biol 1992, 28A:648-656.
27. Cesano A, Santoli D: Inducible expression of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and interferon-gamma in two human cytotoxic leukemic T-cell lines. In Vitro Cell Dev Biol 1992, 28A:657-662.
28. Betts MR, Brenchley JM, Price DA, Rosa SC De, Douek DC, Roederer M, Koup RA: Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003, 281:65-78.
29. Rubio V, Stuge TB, Singh N, Betts MR, Weber JS, Roederer M, Lee PP: Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat Med 2003, 9:1377-1382.
30. Trincieri G: Biology of natural killer cells. Adv Immunol 1989, 47:187-376.
31. Kleen TO, Asaad R, Landry SJ, Boehm BO, Tary-Lehmann M: Tc1 effector diversity shows dissociated expression of granzyme B and interferon-gamma in HIV infection. AIDS 2004, 18:383-392.
32. Trapani JA, Smyth MJ: Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2002, 2:735-747.
33. Papamichail M, Perez SA, Gritzapis AD, Baxevanis CN: Natural killer lymphocytes: biology, development, and function. Cancer Immunol Immunother 2004, 53:176-186.
34. Sciaky N, Presley J, Smith C, Zaal KJ, Cole N, Moreira JE, Terasaki M, Siggia E, Lippincott-Schwartz J: Golgi tubule traffic and the effects of brefeldin A visualized in living cells. J Cell Biol 1997, 139:1137-1155.
35. Lyubchenko TA, Wurth GA, Zweifach A: Role of calcium influx in cytotoxic T lymphocyte lytic granule exocytosis during target cell killing. Immunity 2001, 15:847-859.
36. Keilholz U, Weber J, Finke JH, Gabrilovich DI, Kast WM, Disis ML, Kirkwood JM, Scheibenbogen C, Schlom J, Maino VC, Lyerly HK, Lee PP, Storkus W, Marincola F, Worobec A, Atkins MB: Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy. J Immunother 2002, 25:97-138.
37. Derby EG, Reddy V, Nelson EL, Kopp WC, Baseler MW, Dawson JR, Malyguine AM: Correlation of human CD56+ cell cytotoxicity and IFN-gamma production. Cytokine 2001, 13:85-90.
38. Bladergroen BA, Meijer CJ, Berge RL ten, Hack CE, Muris JJ, Dukers DF, Chott A, Kazama Y, Oudejans JJ, Berkum O van, Kummer JA: Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system? Blood 2002, 99:232-237.
39. Goepfert PA, Bansal A, Edwards BH, Ritter GD Jr, Tellez I, McPherson SA, Sabbaj S, Mulligan MJ: A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon. J Virol 2000, 74:10249-10255.
40. Kaul R, Plummer FA, Kimani J, Dong T, Kiama P, Rostron T, Njagi E, MacDonald KS, Bwayo JJ, McMichael AJ, Rowland-Jones SL: HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi. J Immunol 2000, 164:1602-1611.
41. Kaul R, T T Dong, Plummer FA, Kimani J, Rostron T, Kiama P, Njagi E, Irungu E, Farah B, Oyugi J, Chakraborty R, MacDonald KS, JJ JJ Bwayo, McMichael A, Rowland-Jones SL: CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects. J Clin Invest 2001, 107:1303-1310.
42. Currier JR, Kuta EG, Turk E, Earhart LB, Loomis-Price L, Janetzki S, Ferrari G, Birx DL, Cox JH: A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays. J Immunol Methods 2002, 260:157-172.
43. Altfeld M, Addo MM, Eldridge RL, Yu XG, Thomas S, Khatri A, Strick D, Phillips MN, Cohen GB, Islam SA, Brander SA Kalams C, Goulder PJ, Rosenberg ES, Walker BD: Vpr is preferentially targeted by CTL during HIV-1 infection. J Immunol 2001, 167:2743-2752.
44. Regner M, Lobigs M, Blanden RV, Mullbacher A: Effector cytolotic function but not IFN-gamma production in cytotoxic T cells triggered by virus-infected target cells in vitro. Scand J Immunol 2001, 54:366-374.
45. Lim DG, Bourcier K Bieganowska, Freeman GJ, Hafler DA: Examination of CD8+ T cell function in humans using MHC class I tetramers: similar cytotoxicity but variable proliferation and cytokine production among different clonal CD8+ T cells specific to a single viral epitope. J Immunol 2000, 165:6214-6220.
46. Slifka MK, Rodriguez F, Whitton JL: Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells. Nature 1999, 401:76-79.
47. Bachmann MF, Barner M, Viola A, Kopf M: Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection. Eur J Immunol 1999, 29:291-299.
48. Masopust D, Vezys V, AL AL Marzo, L L Lefrancois: Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001, 291:2413-2417.
49. Bleackley RC, Lobe CG, Duggan B, Ehrman N, Fregeau C, M M Meier, Letellier M, Havele C, Shaw J, Paetkau V: The isolation and characterization of a family of serine protease genes expressed in activated cytotoxic T lymphocytes. Immunol Rev 1988, 103:5-19.
50. Burkhardt JK, Hester S, Lapham CK, Argon Y: The lytic granules of natural killer cells are dual-function organelles combining secretory and pre-lysosomal compartments. J Cell Biol 1990, 111:2327-2340.